Climb Bio CLYM Institutional Ownership

Climb Bio, Inc. (NASDAQ:CLYM) is held by 111 institutional investors per 13F filings through June 2026.

• Their combined ownership stood at 74.1% of outstanding shares in June 2026, up from 47.3% in March 2026.
• They increased total shares held in Climb Bio by 116.86% from the prior quarter, while the number of investors in CLYM increased 65.67% year over year.
• Among the 111 funds, 86 bought more Climb Bio shares, 18 sold down, and 7 held their ground.
• Institutional investors collectively held 56.43Mn shares in Climb Bio as of June 2026, up by 30.41Mn shares quarter on quarter, and up 6.78Mn shares year over year.
• RA CAPITAL MANAGEMENT, L.P. is the top holder of Climb Bio as of June 30, 2026, with 11.3Mn shares representing 14.84% of outstanding stock.
• The largest buyers of Climb Bio for the quarter ending June 2026 were FMR LLC (6.78Mn), UBS Group AG (3.32Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.51Mn), Cormorant Asset Management, LP (2.11Mn), BlackRock, Inc. (1.95Mn).
• The largest sellers of Climb Bio for the quarter ending June 2026 were MILLENNIUM MANAGEMENT LLC (368.06K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (357.12K), GREAT POINT PARTNERS LLC (334.13K), TWO SIGMA INVESTMENTS, LP (162.37K), Verdad Advisers, LP (98.42K).
• Climb Bio's 10 largest shareholders as of June 2026 include RA CAPITAL MANAGEMENT, L.P. (11.3Mn), FMR LLC (6.79Mn), UBS Group AG (3.4Mn), BRAIDWELL LP (2.8Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.51Mn), BlackRock, Inc. (2.35Mn), PRICE T ROWE ASSOCIATES INC /MD/ (2.13Mn), Cormorant Asset Management, LP (2.11Mn), FRONTIER CAPITAL MANAGEMENT CO LLC (1.94Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.7Mn) per Business Quant data.